BestPractice MEDtalk

– Utdannelse og faglig dialog

Fastleger

17:45

GOLD Guidelines

GOLD-guidelines ved behandling av KOLS er nylig oppd…

<script src="https://fast.wistia.com/embed/medias/lg4ev92l31.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_lg4ev92l31 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
11:27

Clinical proof points

Professor Matthias Born viser i denne MEDtalk den kliniske dokument…

<script src="https://fast.wistia.com/embed/medias/nhctpu0m5k.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_nhctpu0m5k videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
9:25

Lights and research

Gjennom denne korte BestPractice MEDtalks følger vi forsker og pro…

<script src="https://fast.wistia.com/embed/medias/tl4rqcikrq.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_tl4rqcikrq videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:45

Philips Blue Light Control

Professor Matthias Born viser i denne MEDtalk devicet som er utvikl…

<script src="https://fast.wistia.com/embed/medias/0qpu1nlstc.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_0qpu1nlstc videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
MEDtalk Plilips Blue Control med Matthias Born 6:11

Trends i light treatment

En ny type fototerapi er utviklet for plakkpsoriasis ved bruk av bl…

<script src="https://fast.wistia.com/embed/medias/79qq74gaeh.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_79qq74gaeh videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Tone Victoria Hjelset MEDtalk BestPractice 14:47

Positiv adferdsendring hos diabetespasienter

I denne MEDtalken forteller forsker ved seksjon for folkehelseviten…

<script src="https://fast.wistia.com/embed/medias/af8e2r3ojx.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_af8e2r3ojx videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
8:31

Urinsyreavleiringer

I denne MEDtalken med assisterende avdelingsoverlege Hilde Berner …

<script src="https://fast.wistia.com/embed/medias/np8d7nt1t4.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_np8d7nt1t4 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Till Ulig MEDtalk BestPrac 6:25

Kort om diagnostisering og behandling av urinsyregikt

I denne MEDtalken med professor Till Uhlig får du økt bevissthet …

<script src="https://fast.wistia.com/embed/medias/4mxi06u4ex.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_4mxi06u4ex videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Kristian Furusteh BestPractice 18:57

Insuliner og kombinasjonsbehandling

I webinaret forteller fastlege Kristian Furuseth om insuliner og ko…

<script src="//fast.wistia.com/embed/medias/jib9eh5tc3.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_jib9eh5tc3 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Trond Jenssen BestPractice utdannelse 15:40

Nyresykdom ved diabetes

I webinaret forteller professor Trond Jenssen om den siste oppdatering…

<script src="//fast.wistia.com/embed/medias/k0as3asvkw.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_k0as3asvkw videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Trond G. Jenssen BestPractice webinar 18:17

Blodsukkersenkende medikamentell behandling ved diabetes type 2

I webinaret forteller professor Trond Jenssen om den siste oppdatering…

<script src="//fast.wistia.com/embed/medias/di38ncne2z.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_di38ncne2z videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Trond G. Janssen webinar på BestPractice

Nytt om diabetes og kardiovaskulær risiko

Pasienter med diabetes har økt risiko for å dø av hjertekarsykdom. …

<script src="//fast.wistia.com/embed/medias/blnhgkdhla.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_blnhgkdhla videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

Dermatologi

11:27

Clinical proof points

Professor Matthias Born viser i denne MEDtalk den kliniske dokument…

<script src="https://fast.wistia.com/embed/medias/nhctpu0m5k.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_nhctpu0m5k videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
9:25

Lights and research

Gjennom denne korte BestPractice MEDtalks følger vi forsker og pro…

<script src="https://fast.wistia.com/embed/medias/tl4rqcikrq.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_tl4rqcikrq videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:45

Philips Blue Light Control

Professor Matthias Born viser i denne MEDtalk devicet som er utvikl…

<script src="https://fast.wistia.com/embed/medias/0qpu1nlstc.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_0qpu1nlstc videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
MEDtalk Plilips Blue Control med Matthias Born 6:11

Trends i light treatment

En ny type fototerapi er utviklet for plakkpsoriasis ved bruk av bl…

<script src="https://fast.wistia.com/embed/medias/79qq74gaeh.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_79qq74gaeh videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

Diabetes / Hjerte-Kar

11:39

Innvandrer og diabetes

Det er ingen grunn til at innvandrerbefolkningen med diabetes ikke …

<script src="https://fast.wistia.com/embed/medias/wzjkmx1fk1.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_wzjkmx1fk1 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Tone Victoria Hjelset MEDtalk BestPractice 14:47

Kommunikasjon, mestring og motivasjon ved diabetes

I denne MEDtalk-en forteller forsker ved seksjon for folkehelsevite…

<script src="https://fast.wistia.com/embed/medias/af8e2r3ojx.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_af8e2r3ojx videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Kristian Furusteh BestPractice 18:57

Insuliner og kombinasjonsbehandling

I webinaret forteller fastlege Kristian Furuseth om insuliner og ko…

<script src="//fast.wistia.com/embed/medias/jib9eh5tc3.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_jib9eh5tc3 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Trond Jenssen BestPractice utdannelse 15:40

Nyresykdom ved diabetes

I webinaret forteller professor Trond Jenssen om den siste oppdatering…

<script src="//fast.wistia.com/embed/medias/k0as3asvkw.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_k0as3asvkw videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Trond G. Jenssen BestPractice webinar 18:17

Blodsukkersenkende medikamentell behandling ved diabetes type 2

I webinaret forteller professor Trond Jenssen om den siste oppdatering…

<script src="//fast.wistia.com/embed/medias/di38ncne2z.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_di38ncne2z videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Trond G. Janssen webinar på BestPractice

Nytt om diabetes og kardiovaskulær risiko

Pasienter med diabetes har økt risiko for å dø av hjertekarsykdom. …

<script src="//fast.wistia.com/embed/medias/blnhgkdhla.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_blnhgkdhla videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

Infeksjonsmedisin

9:48

LARs arbeide i Norge

Hør intervjuet med prosjektleder i LAR, Bent- Arild Stornes fortelle …

BestPractice besøkte INSHU symposiet og har gjort opptak og korte intervjuer med norske leger og andre som er engasjert i kampen mot HCV og som på INHSU bidro med innlegg og postere.
15:38

Ekstrahepatiske Manifestasjoner av HCV infiserte

Hør foredraget til professor Olav Dalgard om Ekstrahepatiske Manifest…

<script src="https://fast.wistia.com/embed/medias/f758la3y08.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_f758la3y08 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
13:22

C-EDGE COSTAR resultatene

Hør foredraget til professor Olav Dalgard om C-EDGE COSTAR resultaten…

<script src="https://fast.wistia.com/embed/medias/hj64uaitbp.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_hj64uaitbp videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
INSHU 2016 Olov Dalgard 1:24

Forskning gjort på fibrosegrad hos rusmiddelbrukere

Hør hva professor Olav Dalgard fortelle fra sin poster på INHSU om f…

<script src="https://fast.wistia.com/embed/medias/v40h9mbpug.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_v40h9mbpug videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:18

Olov Dalgard forteller om INSHU

Hør hva Olav Dalgard som er president for INSHU fortelle om symposiet…

<script src="https://fast.wistia.com/embed/medias/ujfl28fkyh.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_ujfl28fkyh videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Olov Dalgard på INSHU i Oslo 2016 2:35

Genotype 3 er den vanskeligste HCV formen å behandle

BestPractice besøkte INSHU symposiet og har gjort opptak og korte int…

<script src="https://fast.wistia.com/embed/medias/unli2ble1o.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_unli2ble1o videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Olov Dalgard fra INSHU 2016 2:29

Behandling med et nytt DAA tilgjengelig

BestPractice besøkte INSHU symposiet og har gjort opptak og korte int…

<script src="https://fast.wistia.com/embed/medias/hdklu43ip9.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_hdklu43ip9 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Bo Kielland INSHU 2016 15:42

HCV og fatigue hos pasienter som er smittet med hepatitt Knut Boe Kielland

BestPractice besøkte INSHU symposiet og har gjort opptak og korte int…

<script src="https://fast.wistia.com/embed/medias/ktgfv50oun.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_ktgfv50oun videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

Lungemedisin

17:45

GOLD Guidelines

GOLD-guidelines ved behandling av KOLS er nylig oppd…

<script src="https://fast.wistia.com/embed/medias/lg4ev92l31.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_lg4ev92l31 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

Onkologi /hematologi

15:44

Håndtering av bivirkninger ved immunterapi

Forekomst…

<script src="https://fast.wistia.com/embed/medias/3v3vzfzirz.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_3v3vzfzirz videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
4:50

Hvordan vurderes effekt av immunterapi-behandlingen - radiologisk og klinisk

<script src="https://fast.wistia.com/embed/medias/49ijzhno1v.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_49ijzhno1v videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
9:59

Biomarkører ved immunterapi

<script src="https://fast.wistia.com/embed/medias/rmcnle0xcb.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_rmcnle0xcb videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

Virkningsmekanismer ved immunterapi

<script src="https://fast.wistia.com/embed/medias/s77pzl2vjn.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_s77pzl2vjn videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
9:30

Status på opfølgning og behandling af follikulære lymfomer i Norge

I to moduler diskuterer Alexander Fosså og Bjørn Østedstad aktu…

<script src="https://fast.wistia.com/embed/medias/q10y6j69m3.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_q10y6j69m3 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
7:26

Status på behandling af Hodgins lymfom i Norge

I to moduler diskuterer Alexander Fosså og Bjørn Østedstad aktu…

<script src="https://fast.wistia.com/embed/medias/zmsbdq7wh7.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_zmsbdq7wh7 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
14:30

Behandling av follikulært lymfom

Bjørn Østenstad redegjør for behandling av follikulært lymfom o…

<script src="https://fast.wistia.com/embed/medias/zs2qcl3i0v.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_zs2qcl3i0v videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
14:12

Behandling av Hodgins lymfom

I denne videoen redegjør Alexander Fossе for behandling av Hodgin…

<script src="https://fast.wistia.com/embed/medias/h3h2whi785.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_h3h2whi785 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Inge Marie Svane 10:32

Highlights fra ESMO om immunterapi

Totalt 45 sesjoner ved ESMO-konferansen handlet om immunterapi og er e…

<script src="https://fast.wistia.com/embed/medias/9g8hgsw4ab.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_9g8hgsw4ab videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:23

Paradigmeskifte på vei i behandling av lungekreft

Data fra PACIFIK-studien viser at immunterapi tredobler overlevelsen v…

<script src="https://fast.wistia.com/embed/medias/at9ka34qf8.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_at9ka34qf8 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:23

Abirateronacetat gir overlevelsesgevinst ved additiv behandling

Overlege og onkolog Jan Oldenburg, Akershus Universitetssykehus, forte…

<script src="https://fast.wistia.com/embed/medias/0u589i5gu4.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_0u589i5gu4 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:22

Melanompasienter får lengre DFS med adjuvant vemurafenib sammenlignet med placebo

Karl Lewis, associate professor of medicine, Division of Medical On…

<script src="https://fast.wistia.com/embed/medias/ts4c3gv8pz.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_ts4c3gv8pz videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
1:43

Behandling av høy risiko pasienter med melanom endres

På ESMO ble det fremlagt flere studier på melanom som vil endre beha…

<script src="https://fast.wistia.com/embed/medias/ysdwixpdvg.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_ysdwixpdvg videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:05

Immunterapi gir bedre progresjonsfri overlevelse enn strålebehandling hos lungekreftpasienter

Overlege Åslaug Helland, OUS, gir her en kort status rapport på nye …

<script src="https://fast.wistia.com/embed/medias/tuib1udnh8.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_tuib1udnh8 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:43

T-celle terapi mot eggstokk-kreft

Magnus Pedersen, Center for cancer immunterapi, Herlev Hospital, freml…

<script src="https://fast.wistia.com/embed/medias/khgh87a9mq.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_khgh87a9mq videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:37

Vaksine mot ikke-småcellet lungekreft i stadium III-IV

Kan vaksine bli en fremtidig behandling av lungekreft? Svaret på dett…

<script src="https://fast.wistia.com/embed/medias/vglzy3wjhd.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_vglzy3wjhd videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
13:24

Sequencing therapy in multiple myeloma

Hør Philippe Moreau, Head of the Hematology Depar…

<script src="https://fast.wistia.com/embed/medias/52d5uq5kvv.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_52d5uq5kvv videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
11:55

How to treat patients in relapse following frontline ASCT

Best Practice har besøkt Philippe Moreau i Nantes og laget eksklus…

<script src="https://fast.wistia.com/embed/medias/j2on9wxcvw.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_j2on9wxcvw videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:24

Ny kandidat til 1. linjebehandling av EGFR-mutert ikke-småcellet lungekreft

Suresh S. Ramalingam, professor og director ved Winship Cancer Institu…

<script src="https://fast.wistia.com/embed/medias/e485ti378a.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_e485ti378a videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
1:59

Svikt av standard immunterapi ved malignt melanom

Pasienter med metastaserende malign melanom, som ikke responderer tils…

<script src="https://fast.wistia.com/embed/medias/c7d5xa37tt.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_c7d5xa37tt videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:40

Viktig med faglig nettverk for sjeldne kreftsykdommer

Sjeldne cancersykdommer er ofte aggressive og rammer ofte yngre pasien…

<script src="https://fast.wistia.com/embed/medias/v5bdoflbl0.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_v5bdoflbl0 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
1:59

Pembrolizumab - ny standard som andrelinje behandling ved blærekreft

Behandling med Pembrolizumab tolereres godt, forlenger overlevelsen…

<script src="https://fast.wistia.com/embed/medias/c96u3exf58.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_c96u3exf58 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Fredrik Schjesvold Medtalk fra EHA 2017 Madrid 2:05

EHA - Behandlinger på vei til Norge på myelomatose

I videoen forteller overlege Fredrik Schjesvold, OUS, om de mange n…

<script src="https://fast.wistia.com/embed/medias/ws8v1xm9ct.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:55.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_ws8v1xm9ct videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Fredrik Schjesvold Medtalk fra EHA 2017 3:46

Kort statusrapport på myelomatose fra årets EHA kongress i Madrid

Overlege Fredrik Schjesvold, OUS, gir en kort status på nye behand…

<script src="https://fast.wistia.com/embed/medias/w6srn5skki.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:55.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_w6srn5skki videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
ESMO 2016 42:34

Ny epoke i behandling av lungekreft

Der er med rette store forventninger til 2017. For det e…

<script src="//fast.wistia.com/embed/medias/b3mrtjpp0a.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_b3mrtjpp0a videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
25:00

Eivind Galteland går gjennom behandlingsalternativer ved KLL

Overlege Eivind Galteland ved Rikshospitalet snakker behandling av …

<script src="//fast.wistia.com/embed/medias/8osse9u9d4.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_8osse9u9d4 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Samtale mellem Eivind Galteland og Carsten Niemann 13:50

KLL BEHANDLING I 2017

Har du fått med deg oppdateringen på Kronisk Lymfatisk Leukemi? N…

<script src="//fast.wistia.com/embed/medias/62awlmxb7f.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_62awlmxb7f videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Carsten Niemann KLL MEDtalk BestPractice 23:37

Carsten Niemann, gir en oppdatering av de danske behandlingsanbefalinger ved KLL

Medlem av den danske guidelinekomitè Carsten Niemann ved Rigshospi…

<script src="//fast.wistia.com/embed/medias/fshz4mhvr8.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_fshz4mhvr8 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
1:04

KLL intro

<script src="//fast.wistia.com/embed/medias/1vm3o1t5yy.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_1vm3o1t5yy videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
20:00

Nye guidelines Kronisk Lymfatisk Leukemi

Har du fått med deg oppdateringen på Kronisk Lymfatisk Leukemi? N…

<script src="//fast.wistia.com/embed/medias/1vm3o1t5yy.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_1vm3o1t5yy videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
BestPractice webinar med paneldiskusjon

Paneldiskusjonen om myelomatose

Paneldiskusjonen med hematologene Nina Gulbrandsen, Einar Haukås og A…

<script src="//fast.wistia.com/embed/medias/wyle1kb80w.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_wyle1kb80w videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Philippe Moreau BestPractice webinar

Nye behandlingsmuligheter for pasienter med myelomatose

Gratis webinar med ekspertene Philippe Moureau og Anders Waage – panel…

<script src="//fast.wistia.com/embed/medias/u9a8zol34b.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_u9a8zol34b videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

ESMO 2017

Inge Marie Svane 10:32

Highlights fra ESMO om immunterapi

Totalt 45 sesjoner ved ESMO-konferansen handlet om immunterapi og er e…

<script src="https://fast.wistia.com/embed/medias/9g8hgsw4ab.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_9g8hgsw4ab videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:23

Paradigmeskifte på vei i behandling av lungekreft

Data fra PACIFIK-studien viser at immunterapi tredobler overlevelsen v…

<script src="https://fast.wistia.com/embed/medias/at9ka34qf8.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_at9ka34qf8 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:23

Abirateronacetat gir overlevelsesgevinst ved additiv behandling

Overlege og onkolog Jan Oldenburg, Akershus Universitetssykehus, forte…

<script src="https://fast.wistia.com/embed/medias/0u589i5gu4.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_0u589i5gu4 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:22

Melanompasienter får lengre DFS med adjuvant vemurafenib sammenlignet med placebo

Karl Lewis, associate professor of medicine, Division of Medical On…

<script src="https://fast.wistia.com/embed/medias/ts4c3gv8pz.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_ts4c3gv8pz videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
1:43

Behandling av høy risiko pasienter med melanom endres

På ESMO ble det fremlagt flere studier på melanom som vil endre beha…

<script src="https://fast.wistia.com/embed/medias/ysdwixpdvg.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_ysdwixpdvg videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:05

Immunterapi gir bedre progresjonsfri overlevelse enn strålebehandling hos lungekreftpasienter

Overlege Åslaug Helland, OUS, gir her en kort status rapport på nye …

<script src="https://fast.wistia.com/embed/medias/tuib1udnh8.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_tuib1udnh8 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:43

T-celle terapi mot eggstokk-kreft

Magnus Pedersen, Center for cancer immunterapi, Herlev Hospital, freml…

<script src="https://fast.wistia.com/embed/medias/khgh87a9mq.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_khgh87a9mq videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
3:37

Vaksine mot ikke-småcellet lungekreft i stadium III-IV

Kan vaksine bli en fremtidig behandling av lungekreft? Svaret på dett…

<script src="https://fast.wistia.com/embed/medias/vglzy3wjhd.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_vglzy3wjhd videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:24

Ny kandidat til 1. linjebehandling av EGFR-mutert ikke-småcellet lungekreft

Suresh S. Ramalingam, professor og director ved Winship Cancer Institu…

<script src="https://fast.wistia.com/embed/medias/e485ti378a.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_e485ti378a videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
1:59

Svikt av standard immunterapi ved malignt melanom

Pasienter med metastaserende malign melanom, som ikke responderer tils…

<script src="https://fast.wistia.com/embed/medias/c7d5xa37tt.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_c7d5xa37tt videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
2:40

Viktig med faglig nettverk for sjeldne kreftsykdommer

Sjeldne cancersykdommer er ofte aggressive og rammer ofte yngre pasien…

<script src="https://fast.wistia.com/embed/medias/v5bdoflbl0.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_v5bdoflbl0 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
1:59

Pembrolizumab - ny standard som andrelinje behandling ved blærekreft

Behandling med Pembrolizumab tolereres godt, forlenger overlevelsen…

<script src="https://fast.wistia.com/embed/medias/c96u3exf58.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_c96u3exf58 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

ESMO2016NO

ESMO 2016 42:34

Ny epoke i behandling av lungekreft

Der er med rette store forventninger til 2017. For det e…

<script src="//fast.wistia.com/embed/medias/b3mrtjpp0a.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_b3mrtjpp0a videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>

Revmatologi

21:07

The importance of early diagnosis and new treatment of RA

This Medtalk is a conversation among former EULAR president and Pro…

<script src="https://fast.wistia.com/embed/medias/6mogui3vcv.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_6mogui3vcv videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Tore Kvien MEDtalk BestPractice 4:46

NOR-SWITCH-studien publisert i The Lancet

En norsk studie viser at det er trygt å bytte fra kostbar original…

<script src="https://fast.wistia.com/embed/medias/tq90mtjz2s.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.0% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_tq90mtjz2s videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Tore Kvien MEDtalk BestPractice 12:58

Ny tablettbehandling godkjent til revmatoid artritt (RA)

I denne MEDtalken redegjør Tore Kristian Kvien, professor og avdel…

<script src="https://fast.wistia.com/embed/medias/zu64sdqb6c.jsonp" async></script><script src="https://fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_zu64sdqb6c videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Tore Kvien MEDtalk BestPractice 4:42

Nye anbefalinger om revmatisk sykdom og hjertesykdom

Få med deg de siste anbefalinger av revmatolog og professor Tore K. K…

<script src="//fast.wistia.com/embed/medias/hloo8b7dd7.jsonp" async></script><script src="//fast.wistia.com/assets/external/E-v1.js" async></script><div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"><div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><div class="wistia_embed wistia_async_hloo8b7dd7 videoFoam=true" style="height:100%;width:100%">&nbsp;</div></div></div>
Se også

Se også

Kristian Furusteh BestPractice

Insuliner og kombinasjonsbehandling

Speaker: Kristian Furuseth

Spilletid: 18:57

Trond Jenssen BestPractice utdannelse

Nyresykdom ved diabetes

Speaker: Trond G. Jenssen

Spilletid: 15:40